Asgard Therapeutics (ASGD) Appoints Wolfram Brugger as CMO
Published on 4/14/2026
AI Summary
Asgard Therapeutics (ASGD) announced the appointment of Wolfram Brugger as chief medical officer. This change is expected to enhance the company’s clinical development capabilities. Brugger brings extensive experience in medical leadership, having previously held senior roles in other biotech firms. This move may improve stakeholder confidence and strategic direction within the company, reflecting on future growth potential.
Related News
Earnings
Replimune (RMNI) Stock Surges 40% on FDA Approval Path Agreement
May 29
M&A
Innovent (HK:1801) Shares Rise 10% After $10.5 Billion Pfizer Deal
May 29
Health
Cancer Treatment Costs Could Rise Significantly in Future Outlook
May 27
Tech
OpenAI (AI) Faces Leadership Challenges Amid Corporate Liability Issues
May 27